Advanced Sterilization Products Receives CE Mark for New ULTRA GI™ Cycle for Duodenoscopes

Advanced Sterilization Products Announces CE Mark Approval for ULTRA GI™ Cycle

Advanced Sterilization Products GmbH (ASP), a subsidiary of Fortive Corporation, has made significant strides in patient safety with the recent announcement of the CE Mark approval for its ULTRA GI™ Cycle. This advanced innovation for the STERRAD™ 100NX Sterilizer, in collaboration with FUJIFILM Healthcare Europe GmbH, promises to redefine how healthcare facilities ensure the safety and efficacy of duodenoscope reprocessing.

A Leap Forward in Patient Safety

The ULTRA GI™ Cycle represents a critical step forward in combating the ongoing infection control challenges associated with duodenoscopes. As noted by ASP’s President, Chad Rohrer, this milestone underscores their commitment to enhancing reprocessing safety across Europe and is an essential part of their mission to use hydrogen peroxide gas plasma sterilization in everyday practices. This method allows healthcare professionals to focus their attention where it matters most—on patient care.

The traditional reprocessing methods of duodenoscopes have often led to heightened concerns about contamination and infection, making innovations like the ULTRA GI™ Cycle vital for patient trust and safety. By achieving CE Mark approval, ASP is rewarding the healthcare community with a more reliable and safer option for duodenoscope sterilization.

Collaboration with FUJIFILM Healthcare

The successful launch of the ULTRA GI™ Cycle is also a testament to the fruitful collaboration between ASP and FUJIFILM Healthcare. As ASP expands its technology platform, the introduction of new duodenoscope models, such as the ED-840T and ED-840XT from FUJIFILM, illustrates the potential for future innovations in medical device compatibility with hydrogen peroxide sterilization methods.

Adding these new models to the ULTRA GI Cycle enhances ASP's ability to provide cutting-edge solutions, marking a significant advancement not only for the companies involved but also for the patients relying on safe medical practices.

Maximizing Client Investments

Current users of the STERRAD 100NX Sterilizer with ALLClear™ Technology can benefit from the ULTRA GI Cycle through a simple upgrade. This flexibility enables healthcare facilities to leverage their existing investments and enhance their sterilization processes without having to purchase new equipment fully.

Expert Insights

Healthcare experts, including Ivan Salgo, MD, Chief Medical Officer at ASP, attribute the need for such advancements to the historically problematic contamination rates associated with duodenoscopes. The partnership with FUJIFILM Healthcare has yielded a sterilization solution that not only meets but exceeds current industry benchmarks, emphasizing the commitment to improving safety standards for patient care.

Conclusion

The CE Mark approval for the ULTRA GI™ Cycle from Advanced Sterilization Products heralds a new era in the reprocessing of duodenoscopes. With increased confidence in sterilization methods, healthcare professionals can ensure that they provide the highest level of care possible. As the healthcare landscape evolves, collaborations such as this between ASP and FUJIFILM Healthcare will undeniably shape the future of infection prevention and patient safety standards across Europe and beyond.

For those interested in further details about the ULTRA GI™ Cycle, more information can be found on ASP’s official website.

For media inquiries or additional details, please reach out to:
Nuno Azeredo
Vice President, Global Brand Marketing
Advanced Sterilization Products (ASP)
Email: [email protected]

Christina Jones
Vice President, Investor Relations
Fortive Corporation
Email: [email protected]